NCT02426944View on ClinicalTrials.gov

Left Atrial Appendage Closure vs. Novel Anticoagulation Agents in Atrial Fibrillation

PHASE4CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

October 13, 2015

Primary Completion Date

July 20, 2019

Study Completion Date

July 20, 2019

Conditions
Atrial Fibrillation
Interventions
DRUG

NOAC

Medical arm, patients will be treated by NOAC.

DEVICE

Left atrial appendage closure

The patients will be treated by interventional closure of the left atrial appendage.

Trial Locations (1)

10034

Cardiocenter, 3rd Medical School, Charles University and University Hospital Kralovske Vinohrady, Prague

All Listed Sponsors
collaborator

Ministry of Health, Czech Republic

OTHER_GOV

lead

Charles University, Czech Republic

OTHER

NCT02426944 - Left Atrial Appendage Closure vs. Novel Anticoagulation Agents in Atrial Fibrillation | Biotech Hunter | Biotech Hunter